We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.64B
AUM Growth
-$5.38B
Cap. Flow
-$5.43B
Cap. Flow %
-117.01%
Top 10 Hldgs %
24.73%
Holding
584
New
151
Increased
39
Reduced
172
Closed
190
Avg Time Held Equity + Options
2.4 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
2.6 quarters
Avg Time Held Equity only
2.5 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
2.6 quarters

Sector Composition

Rank Sector Weight
1 Consumer Staples 14.01%
2 Technology 13.72%
3 Industrials 11.93%
4 Communication Services 11.93%
5 Consumer Discretionary 11.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KA icon
501
DELISTED
Kineta, Inc. Common Stock
KA
– –
-183
Closed -$246K –
MRNS icon
502
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-27,077
Closed -$583K –
SPLK icon
503
DELISTED
Splunk Inc
SPLK
– –
-229,947
Closed -$11.3M –
PACW
504
CALL
DELISTED
PacWest Bancorp
PACW
– –
-62,200
Closed -$11K –
PACW
505
DELISTED
PacWest Bancorp
PACW
– –
-241,155
Closed -$8.96M –
PACW
506
PUT
DELISTED
PacWest Bancorp
PACW
– –
-62,200
Closed -$20K –
FRGI
507
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
– –
-376,100
Closed -$12.3M –
NUVA
508
DELISTED
NuVasive, Inc.
NUVA
– –
-210,060
Closed -$10.2M –
GCP
509
DELISTED
GCP Applied Technologies Inc.
GCP
– –
-332,773
Closed -$6.63M –
CONE
510
DELISTED
CyrusOne Inc Common Stock
CONE
– –
-20,231
Closed -$923K –
GWB
511
DELISTED
Great Western Bancorp, Inc.
GWB
– –
-294,300
Closed -$8.03M –
XLRN
512
DELISTED
Acceleron Pharma
XLRN
– –
-49,100
Closed -$1.3M –
ALXN
513
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-19,469
Closed -$2.71M –
MIK
514
DELISTED
Michaels Stores, Inc
MIK
– –
-147,000
Closed -$4.11M –
AGN
515
DELISTED
Allergan plc
AGN
– –
-528,403
Closed -$142M –
AAC
516
DELISTED
AAC Holdings
AAC
– –
-10,000
Closed -$198K –
KEYW
517
DELISTED
The KEYW Holding Corporation
KEYW
– –
-345,048
Closed -$2.29M –
HZNP
518
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-195,500
Closed -$3.24M –
BKHU
519
DELISTED
Black Hills Corporation
BKHU
– –
-389,000
Closed -$26.5M –
PF
520
CALL
DELISTED
Pinnacle Foods, Inc.
PF
– –
-24,000
Closed -$51K –
ANDV
521
DELISTED
Andeavor
ANDV
– –
-14,110
Closed -$1.21M –
BWLD
522
DELISTED
Buffalo Wild Wings, Inc.
BWLD
– –
-60,941
Closed -$9.03M –
DD icon
523
DELISTED
Du Pont De Nemours E I
DD
– –
-233,885
Closed -$14.8M –
JOY
524
DELISTED
Joy Global Inc
JOY
– –
-683,900
Closed -$11M –
SCNB
525
DELISTED
Suffolk Bancorp
SCNB
– –
-88,137
Closed -$2.23M –

Similar funds

UBS O'Connor's Q2 2016 Portfolio in Review

As of Q2 2016, UBS O'Connor held 584 positions worth $4.64B, down 54% from $10B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

UBS O'Connor withdrew a net $5.43B in Q2 2016, closing 190 positions and reducing 172 holdings. Its most notable exit was CAMERON INTERNATIONAL CORPORATION, an estimated $229M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 14% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

Against the trend, UBS O'Connor opened a new position in LinkedIn Corporation worth $229M.

  • UBS O'Connor's largest Q2 2016 buy was LinkedIn Corporation: 1,210,490 shares worth $229M.
  • UBS O'Connor added most to EMC CORPORATION in Q2 2016, an estimated $79.3M increase.
  • UBS O'Connor's biggest Q2 2016 reduction was Charles Schwab, cutting an estimated $219M.
  • UBS O'Connor fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $229M.
  • UBS O'Connor's ten largest holdings make up 25% of its $4.64B portfolio in Q2 2016.
  • UBS O'Connor opened 151 new positions and closed 190 in Q2 2016.
  • UBS O'Connor's portfolio value fell 54% quarter-over-quarter to $4.64B.

Based on UBS O'Connor's 13F filing for Q2 2016, filed 12 Aug 2016.